These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1801766)

  • 1. Dopaminergic activity and idiopathic edema.
    Franco K; Tamburrino M; Campbell N; Pentz J; Evans C
    Hosp Community Psychiatry; 1991 Mar; 42(3):309-10. PubMed ID: 1801766
    [No Abstract]   [Full Text] [Related]  

  • 2. Molindone and haloperidol in tardive dyskinesia.
    Glazer WM; Hafez HM; Benarroche CL
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):4-7. PubMed ID: 2862139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nicotine in neuropsychiatric movement disorders].
    Erdmann R
    Fortschr Neurol Psychiatr; 1996 Sep; 64(9):362-6. PubMed ID: 8991874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.
    Thaker GK; Wagman AM; Kirkpatrick B; Tamminga CA
    Biol Psychiatry; 1989 Jan; 25(1):75-86. PubMed ID: 2563233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic edema.
    Rosenberg DR
    Hosp Community Psychiatry; 1991 Oct; 42(10):1072. PubMed ID: 1959905
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.
    De Souza IE; Dawson NM; Clifford JJ; Waddington JL; Meredith GE
    Psychopharmacology (Berl); 2003 Aug; 169(1):28-34. PubMed ID: 12830366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
    Schweitzer JW; Schwartz R; Friedhoff AJ
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of selective dopamine D-1 and D-2 antagonists on the locomotor response and brain monoamine changes induced by naloxone-precipitated morphine withdrawal in guinea pigs.
    Brent PJ; Chahl LA
    Prog Clin Biol Res; 1990; 328():515-8. PubMed ID: 2406762
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.
    Waddington JL; Cross AJ; Gamble SJ; Bourne RC
    Science; 1983 Apr; 220(4596):530-2. PubMed ID: 6132447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980.
    Bravi D; Davis TL; Mouradian MM; Chase TN
    Mov Disord; 1993 Apr; 8(2):195-7. PubMed ID: 8097280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights in Parkinson's disease therapy: can levodopa-induced dyskinesia ever be manageable.
    Hadj Tahar A; Grondin R; Grégoire L; Calon F; Di Paolo T; Bédard PJ
    Adv Neurol; 2003; 91():51-64. PubMed ID: 12442663
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of single and long-term haloperidol administration on open field behavior of rats.
    Bernardi MM; De Souza H; Palermo Neto J
    Psychopharmacology (Berl); 1981; 73(2):171-5. PubMed ID: 6785810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of dopaminergic supersensitivity induced by neuroleptic drugs in mice.
    Yen-Koo HC; Balazs T
    Drug Chem Toxicol; 1980; 3(2):237-47. PubMed ID: 6112126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dopamine receptor agonists to reduce dopamine receptor number as treatment for tardive dyskinesia.
    Alpert M; Friedhoff AJ; Diamond F
    Adv Neurol; 1983; 37():253-8. PubMed ID: 6134444
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible cholinergic mechanism in reserpine and tardive dyskinesia.
    Dilsaver SC; Greden JF
    Am J Psychiatry; 1984 Jan; 141(1):151-2. PubMed ID: 6691448
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.
    Turjanski N; Fernandez W; Lees AJ
    J Neurol Neurosurg Psychiatry; 1993 Jul; 56(7):771-5. PubMed ID: 8331352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The brain dopamine receptors in chronically alcoholized animals with different relationships to alcohol].
    Bondarenko TT; Vekshina NL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):168-71. PubMed ID: 1316008
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptics and nicotine].
    Erdmann R
    Psychiatr Prax; 1995 Nov; 22(6):223-7. PubMed ID: 8570751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal hyperpyrexia after withdrawal of levodopa.
    Sechi GP; Tanda F; Mutani R
    Neurology; 1984 Feb; 34(2):249-51. PubMed ID: 6538021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.